Zynex Book Value 2011-2026 | ZYXI

Book value is a financial metric that reflects the value of a company's assets minus its liabilities as of a specific date, according to accounting records. In simple terms, it is the amount that would remain for the owners of the company if all assets were sold and all debts paid off.

What is included in book value

Assets — all company resources: real estate, equipment, inventory, cash, accounts receivable, and others.
Liabilities — all debts and financial obligations: loans, accounts payable, taxes, and other obligations.

Features of the metric

Assessment of the company's "real" value
Book value shows how much the company is worth according to accounting data, that is, the value of its property taking debts into account.
Comparison with market capitalization
Comparing book value and the market price of shares helps to understand whether the company is overvalued or undervalued by the market.
Indicator of financial stability
If the book value is high, it indicates the company has significant assets, which reduces risks for investors.
Key component for financial ratios
Many metrics, such as the price-to-book ratio (P/B), use book value to analyze the attractiveness of shares.

Annual Book Value Zynex

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
35.7 M	46.1 M	66.4 M	73.9 M	56.9 M	19.7 M	9.3 M	4.9 M	-3.8 M	-4.07 M	-1.27 M	4.85 M	12.1 M	10.1 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
73.9 M	-4.07 M	23.6 M

Quarterly Book Value Zynex

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-41.4 M	1.26 M	20.8 M	35.7 M	35.8 M	32.8 M	33.1 M	46.1 M	58.6 M	62.3 M	64.5 M	66.4 M	65.2 M	-	75.8 M	73.9 M	63.4 M	57.3 M	56.2 M	56.9 M	56.9 M	56.9 M	56.9 M	19.7 M	19.7 M	19.7 M	19.7 M	9.29 M	9.29 M	9.29 M	9.29 M	4.9 M	4.9 M	4.9 M	4.9 M	-3.8 M	-3.8 M	-3.8 M	-3.8 M	-4.07 M	-4.07 M	-4.07 M	-4.07 M	-1.27 M	-1.27 M	-1.27 M	-1.27 M	4.85 M	4.85 M	4.85 M	4.85 M	12.1 M	12.1 M	12.1 M	12.1 M	10.1 M	10.1 M	10.1 M	10.1 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
75.8 M	-41.4 M	21.4 M

Book Value of other stocks in the Medical devices industry

Issuer	Book Value	Price	% 24h	Market Cap	Country
Acutus Medical AFIB	-879 K	-	-26.83 %	$ 2.62 M	USA
Allied Healthcare Products AHPI	19.7 M	-	3.58 %	$ 2.21 M	USA
AxoGen AXGN	104 M	$ 31.65	-5.55 %	$ 1.4 B	USA
Axonics Modulation Technologies AXNX	570 M	-	-	$ 3.31 B	USA
GenMark Diagnostics, Inc. GNMK	196 M	-	-	$ 1.77 B	USA
Conformis CFMS	54.2 M	-	-	$ 16.4 M	USA
Lianluo Smart Limited LLIT	272 M	-	24.59 %	$ 44.8 M	China
CONMED Corporation CNMD	963 M	$ 43.45	1.31 %	$ 1.34 B	USA
Abiomed ABMD	1.33 B	-	-	$ 17.2 B	USA
Cognyte Software Ltd. CGNT	217 M	$ 9.76	1.99 %	$ 701 M	Israel
Obalon Therapeutics, Inc. OBLN	25.5 M	-	-5.86 %	$ 30.6 M	USA
Apollo Endosurgery APEN	32.6 M	-	-	$ 475 M	USA
Apyx Medical Corporation APYX	26.9 M	$ 3.92	12.33 %	$ 136 M	USA
Alphatec Holdings ATEC	776 M	$ 17.97	-20.68 %	$ 2.57 B	USA
Cutera CUTR	-172 M	-	-10.19 %	$ 1.99 M	USA
Bio-Rad Laboratories BIO	6.57 B	$ 322.91	-0.16 %	$ 9.11 B	USA
Dynatronics Corporation DYNT	3.26 M	-	14.99 %	$ 929 K	USA
Bruker Corporation BRKR	1.82 B	$ 53.33	-2.07 %	$ 7.95 K	USA
BioSig Technologies BSGM	-1.42 M	-	37.08 %	$ 85.7 M	USA
Boston Scientific Corporation BSX	39.4 B	$ 95.53	-2.13 %	$ 141 B	USA
EDAP TMS S.A. EDAP	40.9 M	$ 4.1	11.41 %	$ 153 M	France
Abbott Laboratories ABT	81.4 B	$ 124.29	-1.27 %	$ 216 B	USA
CryoLife, Inc. CRY	58.1 M	-	-4.14 %	$ 702 M	USA
CHF Solutions, Inc. CHFS	6.23 M	-	1.15 %	$ 34.5 M	USA
Soliton, Inc. SOLY	243 M	-	-1.42 %	$ 435 M	USA
Cardiovascular Systems CSII	249 M	-	0.15 %	$ 844 M	USA
Hancock Jaffe Laboratories, Inc. HJLI	2.61 B	-	-1.98 %	$ 98.3 M	USA
Itamar Medical Ltd. ITMR	229 M	-	0.03 %	$ 1.58 B	Israel
Misonix, Inc. MSON	30.4 M	-	-	$ 462 M	USA
Neovasc NVCN	52.2 M	-	-	$ 111 M	Canada
Integra LifeSciences Holdings Corporation IART	1.55 B	$ 13.09	-3.61 %	$ 1.01 B	USA
IRIDEX Corporation IRIX	9.52 M	$ 1.49	29.56 %	$ 24 M	USA
Invacare Corporation IVC	771 M	-	-	$ 24.7 M	USA
Intersect ENT, Inc. XENT	550 M	-	-	$ 955 M	USA
Eargo EAR	101 M	-	-	$ 10.2 M	USA
Electromed ELMD	43.2 M	$ 28.66	-0.49 %	$ 242 M	USA
InMode Ltd. INMD	704 M	$ 14.49	0.35 %	$ 1.15 B	Israel
Pulmonx Corporation LUNG	85.8 M	$ 2.0	-2.21 %	$ 78.2 M	USA
Second Sight Medical Products EYES	17.6 M	-	-0.97 %	$ 54.4 M	USA
Align Technology ALGN	3.85 B	$ 171.78	-0.58 %	$ 12.9 B	USA
Accuray Incorporated ARAY	81.2 M	$ 0.88	-0.46 %	$ 90.4 M	USA
IRadimed Corporation IRMD	86.8 M	$ 97.57	-1.39 %	$ 1.24 B	USA
OrthoPediatrics Corp. KIDS	355 M	$ 20.12	9.89 %	$ 464 M	USA
Avinger AVGR	-6.2 M	-	-20.74 %	$ 369 K	USA
ClearPoint Neuro CLPT	25.4 M	$ 15.66	4.96 %	$ 423 M	USA
FONAR Corporation FONR	146 M	$ 18.6	0.27 %	$ 122 M	USA
GBS GBS	2.81 M	-	-0.57 %	$ 7.12 M	USA
Myomo MYO	6.36 M	$ 0.99	0.29 %	$ 6.98 M	USA
Globus Medical GMED	4.18 B	$ 91.33	-3.28 %	$ 12.4 B	USA